Constriction to hypoxia-reoxygenation in isolated mouse coronary arteries: role of endothelium and superoxide

被引:10
|
作者
Liu, Q [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Johns Hopkins Asthma & Allergy Ctr, Dept Med,Div Pulm & Crit Care Med, Baltimore, MD 21224 USA
关键词
coronary circulation; superoxide anions;
D O I
10.1152/jappl.1999.87.4.1392
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The aim of the present study was to determine the role of endothelium and superoxide in the responses of isolated mouse coronary arteries to hypoxia-reoxygenation. Isolated mouse coronary artery was cannulated, pressurized at 60 mmHg, and constantly superfused with recirculating Krebs-Ringer bicarbonate solution for continuous measurement of intraluminal diameter (ID) by video microscopy. Under a no-flow condition, hypoxia (0% O-2, 30 min) caused vasoconstriction, Reoxygenation caused a further vasoconstriction (ID change from 111.4 +/- 11.1 to 91 +/- 16.5 mu m) that was significantly reduced by removal of endothelium (LD change from 105.4 +/- 27 to 109.9 +/- 23.4 mu m). Cu/Zn superoxide dismutase (150 U/ml) did not alter the hypoxic vasoconstriction but abolished the reoxygenation-caused endothelium-dependent vasoconstriction. Hypoxia-reoxygenation markedly enhanced the generation of superoxide that was significantly reduced by either removing the endothelium or treated these endothelium-intact vessels with superoxide dismutase. These results suggest that, in isolated mouse coronary arteries, hypoxia causes vasoconstriction that is independent of endothelium, whereas reoxygenation causes vasoconstriction that is mediated by enhanced generation of superoxide from endothelium.
引用
收藏
页码:1392 / 1396
页数:5
相关论文
共 50 条
  • [31] Hypoxia-reoxygenation induces neutrophil binding to human adult endothelium under flow conditions
    Homer-Vanniasinkam, S
    Eccles, K
    Estdale, S
    Graham, A
    Parkin, S
    FASEB JOURNAL, 2000, 14 (04): : A705 - A705
  • [32] Coronary vasomotor disorders during hypoxia-reoxygenation:: do calcium channel blockers play a protective role?
    Fernández, AO
    Fernandez, AH
    Dominguez, JMB
    Carretero, EG
    García, JM
    Rodriguez, MP
    Peñas, MMV
    RESEARCH IN EXPERIMENTAL MEDICINE, 2000, 199 (06) : 319 - 331
  • [33] Hypoxia-reoxygenation impairs endothelial function in coronary microarteries mediated by endothelium-derived hyperpolarizing factor: Protective effect of nicorandil
    Dong, YY
    Yim, APC
    Min, W
    He, GH
    DRUG DEVELOPMENT RESEARCH, 2005, 66 (03) : 229 - 229
  • [34] Hypoxia-reoxygenation impairs endothelial function in coronary microarteries mediated by endothelium-derived hyperpolarizing factor: Protective effect of nicorandil
    He, GW
    Dong, YY
    Yim, AP
    Wu, M
    FASEB JOURNAL, 2005, 19 (05): : A1564 - A1564
  • [35] INHIBITORY ROLE OF THE ENDOTHELIUM IN THE RESPONSE OF ISOLATED CORONARY-ARTERIES TO PLATELETS
    COHEN, RA
    SHEPHERD, JT
    VANHOUTTE, PM
    SCIENCE, 1983, 221 (4607) : 273 - 274
  • [36] A role of endothelium for nitroglycerin tolerance in isolated pig coronary arteries.
    Matsuzaki, T
    Sakanashi, M
    Nakasone, J
    Miyagi, K
    Noguchi, K
    Sakanashi, M
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 150P - 150P
  • [37] The Effects of Hypoxia-Reoxygenation in Mouse Digital Flexor Tendon-Derived Cells
    Chen, Chen
    Mao, Wei Feng
    Wu, Ya Fang
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020
  • [38] ISOLATED CARDIAC MYOCYTES ARE SENSITIZED BY HYPOXIA-REOXYGENATION TO NEUTROPHIL-RELEASED MEDIATORS
    BUERKE, M
    WEYRICH, AS
    LEFER, AM
    AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (01): : H128 - H136
  • [39] Role of δ2 Opioid Receptor in Cardioprotection Against Hypoxia-Reoxygenation Injury
    Shen, Hong
    Ben, Qiwen
    Zhang, Yaping
    Jiang, Genxi
    Yao, Chenling
    Shi, Dongwei
    Sun, Zhan
    Tong, Chaoyang
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2012, 60 (03) : 253 - 261
  • [40] Superoxide and endothelium-dependent constriction to flow in porcine small pulmonary arteries
    Liu, Q
    Wiener, CM
    Flavahan, NA
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (02) : 331 - 336